The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid tablets.

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes has remained unchanged—treatment with steroids,

A study reveals Benralizumab as a new treatment for asthma and COPD, reducing treatment failure rates significantly.

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%.

First breakthrough in treating asthma attacks in 50 years hailed as a ‘game-changer’ - Benralizumab is a monoclonal antibody that targets specific white blood cells